Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rallybio (RLYB) Revenue (2024 - 2025)

Rallybio (RLYB) has disclosed Revenue for 2 consecutive years, with $222000.0 as the latest value for Q4 2025.

  • Quarterly Revenue rose 484.21% to $222000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $858000.0 through Dec 2025, up 34.91% year-over-year, with the annual reading at $858000.0 for FY2025, 34.91% up from the prior year.
  • Revenue hit $222000.0 in Q4 2025 for Rallybio, up from $212000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $299000.0 in Q2 2024 to a low of $38000.0 in Q4 2024.